NCT06942767 2025-04-27Combination of QLS31905, QL2107 and Chemotherapy as First-line Therapy in CLDN18.2-positive Unresectable Locally Advanced or Metastatic Gastric or Gastroesophageal Junction (GEJ) AdenocarcinomaQilu Pharmaceutical Co., Ltd.Phase 2 Not yet recruiting100 enrolled